Form 13-F position report

CVS HEALTH CORP

Reported by CLARET ASSET MANAGEMENT Corp

CVS CUSIP 126650100 Manager CIK 0001735513

Reported 276,318 shares, down 7,391 (2.6%) from the prior quarter.

Reported value -19.3%; share count -2.6% vs. the prior quarter.

Reduced
% of reported 13F value 2.5% This manager · Q3 2026
Shares 276,318 Quarter-end amount reported
Reported value $23,678,000 Fair value at quarter end
Consecutive quarters held 36 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 21454000
2022-03-31 21357000
2022-06-30 19698000
2022-09-30 20446000
2022-12-31 20100000
2023-03-31 19192000
2023-06-30 18192000
2023-09-30 19516000
2023-12-31 22130000
2024-03-31 22274000
2024-06-30 16290000
2024-09-30 17182000
2024-12-31 13545000
2025-03-31 20190000
2025-06-30 20445000
2025-09-30 22044000
2025-12-31 22847000
2026-03-31 20776000
2026-06-30 29350000
2026-09-30 23678000

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for CVS HEALTH CORP held by CLARET ASSET MANAGEMENT Corp.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 276,318 -7,391 (-2.6%) 2.5% $23,678,000 2026-11-16
Q2 2026 Reduced 283,709 -5,569 (-1.9%) 3.16% $29,350,000 2026-07-27
Q1 2026 Added 289,278 +1,385 (0.5%) 2.48% $20,776,000 2026-05-11
Q4 2025 Reduced 287,893 -4,501 (-1.5%) 2.65% $22,847,000 2026-02-11
Q3 2025 Reduced 292,394 -3,994 (-1.3%) 2.63% $22,044,000 2025-11-13
Q2 2025 Reduced 296,388 -1,620 (-0.5%) 2.65% $20,445,000 2025-08-13
Q1 2025 Reduced 298,008 -3,735 (-1.2%) 2.91% $20,190,000 2025-05-13
Q4 2024 Added 301,743 +28,500 (10.4%) 2.14% $13,545,000 2025-02-13
Q3 2024 Reduced 273,243 -2,586 (-0.9%) 2.81% $17,182,000 2024-11-14
Q2 2024 Reduced 275,829 -3,437 (-1.2%) 2.9% $16,290,000 2024-08-14
Q1 2024 Reduced 279,266 -1,008 (-0.4%) 3.74% $22,274,000 2024-04-29
Q4 2023 Added 280,274 +751 (0.3%) 3.96% $22,130,000 2024-02-12
Q3 2023 Added 279,523 +16,361 (6.2%) 3.83% $19,516,000 2023-11-13
Q2 2023 Added 263,162 +4,887 (1.9%) 3.55% $18,192,000 2023-08-09
Q1 2023 Added 258,275 +42,590 (19.7%) 3.79% $19,192,000 2023-04-18
Q4 2022 Added 215,685 +1,302 (0.6%) 4.44% $20,100,000 2023-02-07
Q3 2022 Added 214,383 +1,801 (0.8%) 4.85% $20,446,000 2022-11-14
Q2 2022 Added 212,582 +1,570 (0.7%) 4.25% $19,698,000 2022-07-28
Q1 2022 Added 211,012 +3,046 (1.5%) 4.11% $21,357,000 2022-04-04
Q4 2021 Reduced 207,966 -1,860 (-0.9%) 3.97% $21,454,000 2022-02-07
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

2186 managers reported CVS HEALTH CORP for Q3 2026.

Managers reporting CVS HEALTH CORP in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 120,390,157 -2,833,252 0.15% $10,316,232,599 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 83,686,369 +371,000 0.15% $7,171,084,960 3 qtrs
Capital World Investors Reduced 74,043,290 -908,665 0.77% $6,345,353,959 29 qtrs
STATE STREET CORPORATION Reduced 60,087,270 -196,138 0.15% $5,148,878,166 54 qtrs
Dodge & Cox Reduced 46,041,525 -3,971,240 2.11% $3,945,298,277 33 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 36,682,829 +2,881,716 0.56% $3,143,351,616 54 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 30,921,045 +1,021,392 0.14% $2,638,142,619 54 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 27,110,307 +473,048 0.1% $2,323,082,207 3 qtrs
FMR LLC Reduced 24,881,207 -4,039,410 0.09% $2,132,070,581 54 qtrs
Bank of America Corporation Added 23,615,565 +426,895 0.13% $2,023,617,839 54 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
276,318
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.